Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set
Introduction. Hyperlipidemia is an underlying process behind cardiovascular disease. Chinese medicine (CM) may be effective in treating hyperlipidemia, but there is a lack of studies with high methodological quality. A major reason for this is heterogeneity in outcome reporting. Therefore, this stud...
Main Authors: | Geng Li, Ruxue Han, Wencong Cao, Zehuai Wen, Xiankun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/8822215 |
Similar Items
-
A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey
by: Geng Li, et al.
Published: (2019-01-01) -
Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
by: Ruijin Qiu, et al.
Published: (2020-05-01) -
Protocol of the Development of a Core Outcome Set for Ischemic Stroke in Clinical Trials of Chinese Medicine
by: Qianwen Xie, et al.
Published: (2020-01-01) -
Sjogren’s syndrome in clinical trials of traditional Chinese medicine: protocol for the development of a core outcome set
by: Ming Liu, et al.
Published: (2021-03-01) -
Core outcomes in periodontal trials: study protocol for core outcome set development
by: Thomas J. Lamont, et al.
Published: (2017-09-01)